• MMP-Responsive Nanoparticle Hydrogel for Targeted Drug Deliv

  2026-06-15

  This study introduces an injectable hydrogel-nanoparticle system that releases a RANKL inhibitor in response to matrix metalloproteinase activity, enabling sustained, localized therapy for fibrous dysplasia. The innovation addresses disease rebound and systemic side effects, offering a new paradigm for lesion-specific drug delivery.

• Sisomicin in Translational Antibacterial Research: Mechanism

  2026-06-15

  This thought-leadership article bridges mechanistic insights and strategic guidance for translational researchers using Sisomicin, a broad-spectrum aminoglycoside antibiotic. Drawing from recent in vitro resistance research, competitive benchmarking, and advanced workflow recommendations, the article delivers actionable intelligence for those tackling Gram-negative and Gram-positive infections. APExBIO’s Sisomicin is highlighted for its experimental robustness, with protocol parameters, comparative analysis, and forward-looking perspectives to empower the next phase of infection research.

• Live-Dead Cell Staining Kit: Precision Viability Assays Unlo

  2026-06-14

  The Live-Dead Cell Staining Kit empowers researchers with robust, dual-fluorescent quantification of cell viability, outperforming traditional exclusion methods in both sensitivity and reproducibility. Leveraging Calcein-AM and Propidium Iodide dual staining, this workflow is ideal for applications ranging from cytotoxicity testing to advanced biomaterial validation.

• Pentoxifylline Suppresses Hyperinflammation in Preterm Monoc

  2026-06-13

  This study demonstrates that pentoxifylline (PTX) robustly downregulates inflammatory signaling, cytokine production, and phagocytosis in LPS-stimulated monocytes from preterm infants. The findings reveal age-dependent immunomodulatory effects, highlighting the importance of tailored anti-inflammatory strategies in neonatal sepsis research.

• EZH2 Inhibition in HPV-Associated Cervical Cancer: Efficacy

  2026-06-12

  This study investigates the therapeutic effects of EZH2 inhibitors, including EPZ-6438, in human papillomavirus (HPV)-associated cervical cancer. By elucidating the molecular pathways targeted by EZH2 inhibition, the research highlights distinct cellular responses and provides evidence for the potential of epigenetic therapy in HPV-driven malignancies.

• H2O2-Mediated STOP1 Degradation Regulates Aluminum Resistanc

  2026-06-12

  This study reveals that hydrogen peroxide (H2O2) accumulation in plant roots under aluminum (Al) stress promotes oxidation and subsequent degradation of the key transcription factor STOP1, thereby negatively regulating Al resistance in Arabidopsis. The findings highlight new mechanistic details linking oxidative stress, mitochondrial function, and protein stability in plant abiotic stress responses.

• Live-Dead Cell Staining Kit: Precision Cell Viability in Act

  2026-06-11

  Unlock next-generation cell viability workflows with the Live-Dead Cell Staining Kit, leveraging Calcein-AM Propidium Iodide staining for robust, quantitative live/dead discrimination. Discover advanced protocol enhancements, troubleshooting strategies, and translational insights for wound healing and drug cytotoxicity research.

• AMPK–SQSTM1 Feedback Loop Synergizes Antioxidant Defense in

  2026-06-11

  This study uncovers a double-positive feedback loop between AMPK and SQSTM1/p62 under metabolic stress, resulting in dual activation of AMPK and NFE2L2/NRF2 and enhanced antioxidant defense. These findings shed light on metabolic adaptation in tumors with STK11 and KEAP1 mutations and suggest new avenues for therapeutic intervention.

• Pomalidomide (CC-4047): Precision Tools for Tumor Microenvir

  2026-06-10

  Explore the advanced applications of Pomalidomide (CC-4047) in hematological malignancy research, focusing on how its mechanistic precision and genomic compatibility empower next-generation multiple myeloma studies. This article delivers a unique, protocol-oriented perspective on leveraging CC-4047 for robust, translational research.

• CFDA SE Cell Tracer Kit: Technical Guidance for Stable Cell

  2026-06-10

  The CFDA SE (carboxyfluorescein diacetate succinimidyl ester) Cell Tracer Kit enables robust, long-term fluorescent labeling for cell lineage tracing and proliferation studies in both in vitro and in vivo research. It should be chosen for workflows requiring persistent, covalent cell marking but is not appropriate for reversible or short-term cell labeling tasks.

• Gamma-linolenic acid (GLA): Reliable Solutions for Cell Assa

  2026-06-09

  This scenario-driven article details how Gamma-linolenic acid (GLA, SKU C5518) empowers biomedical researchers to overcome core challenges in cell viability, proliferation, and cytotoxicity workflows. By integrating quantitative data, literature-backed protocols, and candid product comparisons, the article demonstrates the reproducibility and scientific utility of GLA, with actionable insights for those advancing anti-inflammatory and apoptosis research.

• Harnessing ARCA Cy3 EGFP mRNA (5-moUTP) for Quantitative mRN

  2026-06-09

  Explore how ARCA Cy3 EGFP mRNA (5-moUTP), a 5-methoxyuridine modified mRNA, enables precise, live-cell quantification of mRNA uptake and translation while minimizing innate immune activation. This article uniquely connects mechanistic advances in endosomal escape and immune evasion to practical assay design, setting a new benchmark for mRNA delivery research.

• Thermosensitive MnO2 Hydrogel for Diabetic Wound ROS Control

  2026-06-08

  This study introduces a multifunctional hydrogel integrating MnO2 nanozymes and TGF-β1 for synergistic diabetic wound therapy. By combining reactive oxygen species (ROS) scavenging, thermoresponsive drug release, and immunomodulation, the hydrogel addresses critical barriers to diabetic wound healing and demonstrates accelerated tissue regeneration in vivo.

• Ertugliflozin (PF-04971729): Advancing SGLT2 Research Protoc

  2026-06-08

  Ertugliflozin (PF-04971729) enables high-fidelity modeling of renal glucose transport and diabesity interventions, setting a new standard for diabetes mellitus research. This guide details protocol enhancements, troubleshooting, and practical tips to maximize data quality and experimental reproducibility.

• Bergenin Targets γδT17 Cells via PPARγ/PROX1 Axis in Psorias

  2026-06-07

  This study uncovers a novel mechanism by which bergenin, a natural PPARγ agonist from Bergenia purpurascens, ameliorates psoriasis by promoting PPARγ-mediated ubiquitination and degradation of PROX1 in γδT17 cells. The findings highlight a targeted metabolic intervention in psoriatic inflammation, providing new avenues for translational research on immune modulation.

16269 records 1/1085 page Next 12345 下5页 Last page